← 產業報告目錄

Nicotine Oral Dissolvable Thin Films Market Research Report Information by Strength (1mg, 2mg, and Others), by Route of Administration (Tongue and Buccal), and by Age Group (Adults and Adolescents), by Sales Channel (Online and Offline), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032

出版商 Market Research Future產業別 Healthcare & Life Sciences出版日期 2024-11-21頁數 146報告編號 MRF-6089520ac5

授權報價

Single User Price$4,950 USD
Multi User Licence (up to 10 users)$5,950 USD
Enterprisewide Price (Global Site License)$7,250 USD
洽詢購買 申請 Sample

報告摘要

Nicotine Oral Dissolvable Thin Films Market Research Report Information by Strength (1mg, 2mg, and Others), by Route of Administration (Tongue and Buccal), and by Age Group (Adults and Adolescents), by Sales Channel (Online and Offline), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032 Overview of the Market In 2023, the market for nicotine oral dissolvable thin films was estimated to be worth USD 0.10 billion. With a compound annual growth rate (CAGR) of 3.86% from 2024 to 2032, the market for nicotine oral dissolveable thin films is expected to increase from USD 0.11 billion in 2024 to USD 0.15 billion by 2032. Increased efforts to stop smoking are driving a significant demand for nicotine oral dissolvable thin films, which is accelerating market expansion in a number of ways. Public health campaigns and government initiatives, such those run by the Office on Smoking and Health (OSH), are actively urging people to quit smoking or reduce their nicotine intake. Programs designed to reduce tobacco use support these efforts by providing resources and skills for implementing effective quitting techniques. Moreover, the worldwide market for nicotine oral dissolvable thin films is mostly driven by the advantages of oral thin film (OTF) technology. A few of the main advantages that support market expansion are listed below. OTFs are a handy and portable way to give nicotine because they dissolve quickly in the mouth and don't require water. They are available for users to use quietly from anywhere at any time. Perspectives on Market Segments The market for nicotine oral dissolvable thin films has been divided into segments based on strength, including 1 mg and 2 mg. The market has been divided into tongue and buccal segments based on the administration route. The market for nicotine oral dissolvable thin films has been divided into two segments based on age: adults and adolescents. The market has been divided into online and offline segments based on the sales channel. Geographic Perspectives The market for nicotine oral dissolvable thin films in North America was valued at USD 31.20 million in 2023 and is anticipated to expand at a compound annual growth rate (CAGR) of 3.86% over the course of the forecast period. The United States and Canada are two more divisions of North America. The growing frequency of smoking-related health problems and growing awareness of smoking cessation aids are driving the market for nicotine oral dissolvable thin films in North America. The market for nicotine oral dissolvable films in Europe was valued at USD 44.48 million in 2023 and is anticipated to expand at a compound annual growth rate (CAGR) of 3.46% over the course of the forecast period. The market for nicotine oral dissolvable thin films in Europe is expected to increase significantly over the next several years because to the growing demand for these products and the presence of competitors. The market for nicotine oral dissolvable films in the Asia-Pacific region was valued at USD 20.74 million in 2023 and is anticipated to expand at a compound annual growth rate (CAGR) of 4.77% over the course of the forecast period. Because of rising health consciousness, urbanization, and the high prevalence of smoking in nations like China, South Korea, India, and Japan, the market for nicotine oral dissolvable thin films in the Asia-Pacific region is expanding significantly. Key Players Nicoccino Holding AB (Japan), AdhexPharma (France), ARx, LLC (US), ZIM Laboratories Limited (India), LTS Lohmann Therapie-Systeme AG (Germany), NAL Pharma (China), INVENTZ Lifesciences (India), Renejix Pharma Solutions (US), and DK Livkon Healthcare Pvt. Ltd. (India) are important players in the nicotine oral dissolvable thin film market.
目錄 Table of Contents
TABLE OF CONTENTS 1 EXECUTIVE SUMMARY 2 MARKET INTRODUCTION 2.1 DEFINITION 2.2 SCOPE OF THE STUDY 2.3 RESEARCH OBJECTIVE 2.4 MARKET STRUCTURE 3 RESEARCH METHODOLOGY 3.1 OVERVIEW 3.2 DATA FLOW 3.2.1 DATA MINING PROCESS 3.3 PURCHASED DATABASE: 3.4 SECONDARY SOURCES: 3.4.1 SECONDARY RESEARCH DATA FLOW: 3.5 PRIMARY RESEARCH: 3.5.1 PRIMARY RESEARCH DATA FLOW: 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE 3.6 APPROACHES FOR MARKET SIZE ESTIMATION: 3.6.1 REVENUE ANALYSIS APPROACH 3.7 DATA FORECASTING 3.7.1 DATA FORECASTING TYPE 3.8 DATA MODELING 3.8.1 MICROECONOMIC FACTOR ANALYSIS: 3.8.2 DATA MODELING: 3.9 TEAMS AND ANALYST CONTRIBUTION 4 MARKET DYNAMICS 4.1 INTRODUCTION 4.2 DRIVERS 4.2.1 INCREASING SMOKING AND TOBACCO CESSATION EFFORTS 4.2.2 ADVANTAGE OF ORAL THIN FILM DRIVES THE MARKET GROWTH 4.3 RESTRAINTS 4.3.1 STRINGENT REGULATORY POLICIES 4.3.2 PRESENCE OF NICOTINE REPLACEMENT THERAPIES 4.3.3 PATENT PROTECTION OF NICOTINE ORAL THIN FILM PRODUCTS 4.4 OPPORTUNITY 4.4.1 INITIATION TO BUILD AND LAUNCH ORAL THIN FILM MANUFACTURING 4.4.2 INNOVATION ASSOCIATED WITH NICOTINE ORAL THIN FILM 5 MARKET FACTOR ANALYSIS 5.1 VALUE CHAIN ANALYSIS 5.1.1 R&D 5.1.2 MANUFACTURING 5.1.3 DISTRIBUTION & SALES 5.2 PORTER'S FIVE FORCES MODEL 5.2.1 THREAT OF NEW ENTRANTS 5.2.2 BARGAINING POWER OF SUPPLIERS 5.2.3 THREAT OF SUBSTITUTES 5.2.4 BARGAINING POWER OF BUYERS 5.2.5 INTENSITY OF RIVALRY 5.3 IMPACT OF COVID-19 ON THE GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET 5.4 QUALITATIVE INFORMATION ON PACKAGING OF NICOTINE ORAL DISSOLVABLE THIN FILMS 5.4.1 PACKAGING MATERIALS 5.4.1.1 FOIL, PAPER, OR PLASTIC POUCHES 5.4.1.2 SINGLE POUCH AND ALUMINUM POUCH 5.4.1.3 BLISTER CARD WITH MULTIPLE UNITS 5.4.1.4 BARRIER FILMS 5.4.2 LABELING AND INFORMATION FOR NICOTINE ORAL DISSOLVABLE THIN FILMS 5.4.2.1 REGULATORY COMPLIANCE 5.4.2.2 NICOTINE DOSAGE 5.4.2.3 WARNINGS AND PRECAUTIONS 5.4.2.4 EXPIRATION DATES 5.5 QUALITATIVE INFORMATION ON END USE OF NICOTINE ORAL DISSOLVABLE THIN FILMS 5.5.1 CHALLENGES IN FORMULATION, STABILITY, AND MANUFACTURING OF ORAL THIN FILM (OTF) 5.5.2 STRINGENT REGULATORY POLICIES FOR THE GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILM MARKET 5.6 QUALITATIVE INFORMATION ON END USE OF NICOTINE ORAL DISSOLVABLE THIN FILMS 5.6.1 SMOKERS & EX-SMOKERS 5.6.2 CONVENIENCE AND DISCREET USE 5.7 PRICING ANALYSIS, BY REGION 2023 (USD) 6 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH 6.1 OVERVIEW 6.2 1MG 6.3 2MG 6.4 OTHERS 7 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION 7.1 OVERVIEW 7.2 TONGUE 7.3 BUCCAL 8 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP 8.1 OVERVIEW 8.2 ADULTS 8.3 ADOLESCENTS 9 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL 9.1 OVERVIEW 9.2 ONLINE 9.3 OFFLINE 10 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION 10.1 OVERVIEW 10.2 NORTH AMERICA 10.2.1 US 10.2.2 CANADA 10.3 EUROPE 10.3.1 GERMANY 10.3.2 FRANCE 10.3.3 UK 10.3.4 ITALY 10.3.5 SPAIN 10.3.6 REST OF EUROPE 10.4 ASIA-PACIFIC 10.4.1 CHINA 10.4.2 INDIA 10.4.3 JAPAN 10.4.4 SOUTH KOREA 10.4.5 AUSTRALIA 10.4.6 REST OF ASIA-PACIFIC 10.5 REST OF THE WORLD 10.5.1 LATIN AMERICA 10.5.2 MIDDLE EAST & AFRICA 11 COMPETITIVE LANDSCAPE 11.1 INTRODUCTION 11.2 MARKET SHARE ANALYSIS, 2023 11.3 COMPETITOR DASHBOARD 11.4 PUBLIC PLAYERS STOCK SUMMARY 11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 11.6.1 AGREEMENT 11.6.2 EXPANSION 11.6.3 PRODUCT APPROVAL 11.6.4 PRODUCT RECOGNITION 12 COMPANY PROFILES 12.1 NICOCCINO HOLDING AB 12.1.1 COMPANY OVERVIEW 12.1.2 FINANCIAL OVERVIEW 12.1.3 PRODUCTS OFFERED 12.1.4 ADDITIONAL INFORMATION 12.1.5 KEY DEVELOPMENTS 12.1.6 SWOT ANALYSIS 12.1.7 KEY STRATEGIES 12.2 NISSHA CO., LTD. 12.2.1 COMPANY OVERVIEW 12.2.2 FINANCIAL OVERVIEW 12.2.3 PRODUCTS OFFERED 12.2.4 ADDITIONAL INFORMATION 12.2.5 KEY DEVELOPMENTS 12.2.6 SWOT ANALYSIS 12.2.7 KEY STRATEGIES 12.3 ADHEXPHARMA 12.3.1 COMPANY OVERVIEW 12.3.2 FINANCIAL OVERVIEW 12.3.3 PRODUCT OFFERED 12.3.4 ADDITIONAL INFORMATION 12.3.5 KEY DEVELOPMENTS 12.3.6 KEY STRATEGIES 12.4 ARX, LLC 12.4.1 COMPANY OVERVIEW 12.4.2 FINANCIAL OVERVIEW 12.4.3 PRODUCTS OFFERED 12.4.4 ADDITIONAL INFORMATION 12.4.5 KEY DEVELOPMENTS 12.4.6 KEY STRATEGIES 12.5 ZIM LABORATORIES LIMITED 12.5.1 COMPANY OVERVIEW 12.5.2 FINANCIAL OVERVIEW 12.5.3 PRODUCTS OFFERED 12.5.4 ADDITIONAL INFORMATION 12.5.5 KEY DEVELOPMENTS 12.5.6 SWOT ANALYSIS 12.5.7 KEY STRATEGIES 12.6 LTS LOHMANN THERAPIE-SYSTEME AG 12.6.1 COMPANY OVERVIEW 12.6.2 FINANCIAL OVERVIEW 12.6.3 PRODUCTS OFFERED 12.6.4 ADDITIONAL INFORMATION 12.6.5 KEY DEVELOPMENTS 12.6.6 SWOT ANALYSIS 12.6.7 KEY STRATEGIES 12.7 NAL PHARMA 12.7.1 COMPANY OVERVIEW 12.7.2 FINANCIAL OVERVIEW 12.7.3 PRODUCTS OFFERED 12.7.4 ADDITIONAL INFORMATION 12.7.5 KEY DEVELOPMENTS 12.7.6 KEY STRATEGIES 12.8 INVENTZ 12.8.1 COMPANY OVERVIEW 12.8.2 FINANCIAL OVERVIEW 12.8.3 PRODUCTS OFFERED 12.8.4 ADDITIONAL INFORMATION 12.8.5 KEY DEVELOPMENTS 12.8.6 SWOT ANALYSIS 12.8.7 KEY STRATEGIES 12.9 RENEJIX PHARMA SOLUTIONS 12.9.1 COMPANY OVERVIEW 12.9.2 FINANCIAL OVERVIEW 12.9.3 SERVICES OFFERED 12.9.4 ADDITIONAL INFORMATION 12.9.5 KEY DEVELOPMENTS 12.9.6 KEY STRATEGIES 12.10 DK LIVKON PVT. LTD 12.10.1 COMPANY OVERVIEW 12.10.2 FINANCIAL OVERVIEW 12.10.3 SERVICES OFFERED 12.10.4 ADDITIONAL INFORMATION 12.10.5 KEY DEVELOPMENTS 12.10.6 KEY STRATEGIES 13 DATA CITATIONS
圖表清單 List of Tables & Figures
LIST OF TABLES TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT TABLE 2 ADVANTAGE OF ORAL THIN FILM TABLE 3 PATENT PROTECTION OF NICOTINE ORAL THIN FILM PRODUCTS TABLE 4 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 5 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR 1MG, BY REGION, 2019–2032 (USD MILLION) TABLE 6 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR 2MG, BY REGION, 2019–2032 (USD MILLION) TABLE 7 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION) TABLE 8 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 9 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR TONGUE, BY REGION, 2019–2032 (USD MILLION) TABLE 10 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR BUCCAL, BY REGION, 2019–2032 (USD MILLION) TABLE 11 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 12 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR ADULTS, BY REGION, 2019–2032 (USD MILLION) TABLE 13 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR ADOLESCENTS, BY REGION, 2019–2032 (USD MILLION) TABLE 14 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 15 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR ONLINE, BY REGION, 2019–2032 (USD MILLION) TABLE 16 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR OFFLINE, BY REGION, 2019–2032 (USD MILLION) TABLE 17 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2019–2032 (USD MILLION) TABLE 18 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2019–2032 (USD MILLION) TABLE 19 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 20 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 21 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 22 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 23 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 24 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 25 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 26 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 27 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 28 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 29 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 30 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 31 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2019–2032 (USD MILLION) TABLE 1 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 2 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 3 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 4 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 5 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 6 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 7 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 8 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 9 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 10 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 11 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 12 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 13 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 14 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 15 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 16 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 17 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 18 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 19 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 20 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 21 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 22 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 23 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 24 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 25 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 26 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 27 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 28 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 29 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2019–2032 (USD MILLION) TABLE 1 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 2 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 3 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 4 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 5 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 6 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 7 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 8 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 9 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 10 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 11 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 12 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 13 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 14 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 15 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 16 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 17 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 18 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 19 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 20 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 21 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 22 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 23 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 24 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 1 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 2 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 3 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 4 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 5 REST OT THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2019–2032 (USD MILLION) TABLE 1 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 2 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 3 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 4 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 5 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 6 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 7 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 8 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 9 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION) TABLE 10 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION) TABLE 11 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION) TABLE 12 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION) TABLE 13 PUBLIC PLAYERS STOCK SUMMARY TABLE 14 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL TABLE 15 AGREEMEENT TABLE 16 EXPANSION TABLE 17 PRODUCT APPROVAL TABLE 18 PRODUCT RECOGNITION TABLE 19 NICOCCINO HOLDING AB: PRODUCTS OFFERED TABLE 20 NICOCCINO HOLDING AB: ADDITIONAL INFORMATION TABLE 21 NISSHA CO., LTD.: PRODUCTS OFFERED TABLE 22 NISSHA CO., LTD.: ADDITIONAL INFORMATION TABLE 23 ADHEXPHARMA: PRODUCTS OFFERED TABLE 24 ADHEXPHARMA: ADDITIONAL INFORMATION TABLE 25 ARX, LLC: PRODUCTS OFFERED TABLE 26 ARX, LLC: ADDITIONAL INFORMATION TABLE 27 ZIM LABORATORIES LIMITED: PRODUCTS OFFERED TABLE 28 ZIM LABORATORIES LIMITED: ADDITIONAL INFORMATION TABLE 29 ZIM LABORATORIES LIMITED: KEY DEVELOPMENTS TABLE 30 LTS LOHMANN THERAPIE-SYSTEME AG: PRODUCTS OFFERED TABLE 31 LTS LOHMANN THERAPIE-SYSTEME AG: ADDITIONAL INFORMATION TABLE 32 NAL PHARMA: PRODUCTS OFFERED TABLE 33 ADDITIONAL INFORMATION TABLE 34 INVENTZ: PRODUCTS OFFERED TABLE 35 INVENTZ: ADDITIONAL INFORMATION TABLE 36 RENEJIX PHARMA SOLUTIONS: SERVICES OFFERED TABLE 37 RENEJIX PHARMA SOLUTIONS: ADDITIONAL INFORMATION TABLE 38 DK LIVKON PVT. LTD: SERVICES OFFERED TABLE 39 DK LIVKON PVT. LTD: ADDITIONAL INFORMATION LIST OF FIGURES FIGURE 1 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET: STRUCTURE FIGURE 2 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032) FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032) FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032) FIGURE 5 VALUE CHAIN ANALYSIS: GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILM MARKET FIGURE 6 MANUFACTURING PROCESS FOR THE NICOTINE ORAL DISSOLVABLE THIN FILM FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET FIGURE 8 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, STRENGTH SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION) FIGURE 9 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2023 & 2032 (USD MILLION) FIGURE 10 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY STRENGTH, 2023 FIGURE 11 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, ROUTE OF ADMINISTRATION SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION) FIGURE 12 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2023 & 2032 (USD MILLION) FIGURE 13 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY ROUTE OF ADMINISTRATION, 2023 FIGURE 14 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, AGE GROUP SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION) FIGURE 15 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2023 & 2032 (USD MILLION) FIGURE 16 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY AGE GROUP, 2023 FIGURE 17 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, SALES CHANNEL SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION) FIGURE 18 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2023 & 2032 (USD MILLION) FIGURE 19 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY SALES CHANNEL, 2023 FIGURE 20 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD MILLION) FIGURE 21 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY REGION, 2023 FIGURE 22 NORTH AMERICA MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2032 (USD MILLION) FIGURE 23 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION) FIGURE 24 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY COUNTRY, 2023 FIGURE 25 EUROPE MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2032 (USD MILLION) FIGURE 26 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD MILLION) FIGURE 27 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY REGION, 2023 FIGURE 28 ASIA-PACIFIC MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2030 (USD MILLION) FIGURE 29 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION) FIGURE 30 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY COUNTRY, 2023 FIGURE 31 REST OF THE WORLD MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2032 (USD MILLION) FIGURE 32 REST OT THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD MILLION) FIGURE 33 REST OT THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY REGION, 2023 FIGURE 34 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023 FIGURE 35 COMPETITOR DASHBOARD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET FIGURE 36 NICOCCINO HOLDING AB: FINANCIAL OVERVIEW SNAPSHOT FIGURE 37 NICOCCINO HOLDING AB: SWOT ANALYSIS FIGURE 38 NISSHA CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 39 NISSHA CO., LTD.: SWOT ANALYSIS FIGURE 40 ZIM LABORATORIES LIMITED: FINANCIAL OVERVIEW SNAPSHOT FIGURE 41 ZIM LABORATORIES LIMITED: SWOT ANALYSIS FIGURE 42 LTS LOHMANN THERAPIE-SYSTEME AG: SWOT ANALYSIS FIGURE 43 INVENTZ: SWOT ANALYSIS

提及公司

Nicoccino Holding AB (Japan)AdhexPharma (France)ARxLLC (US)ZIM Laboratories Limited (India)LTS Lohmann Therapie-Systeme AG (Germany)NAL Pharma (China)INVENTZ Lifesciences (India)Renejix Pharma Solutions (US)and DK Livkon Healthcare Pvt. Ltd. (India)

同分類最新報告(醫療與生命科學)

量子訊息有限公司為 Market Research Future 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們